ArticleFrontiers in neurology
Association of infarct volume with early neurological deterioration in ischemic stroke patients undergoing endovascular treatment.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early neurological deterioration (END) remains a frequent and serious complication after endovascular treatment (EVT) for ischemic stroke (IS), even in patients with successful recanalization. The role of infarct volume in predicting END, particularly in the EVT population, has not been fully clarified. Methods: This retrospective study included IS patients who underwent EVT between January 2020 and June 2025. Clinical, laboratory, procedural, and imaging data were collected. Infarct volume was quantified using 3D-Slicer. END was defined as an NIHSS increase ≥4 points within 24 h post-EVT. Logistic regression analyses were used to identify independent predictors, and ROC curves were applied to evaluate the predictive performance of infarct volume. Results: A total of 682 patients were included, of whom 208 (30.5%) developed END. Multivariate analysis identified systolic blood pressure, atrial fibrillation, triglycerides, the number of EVTs, and infarct volume as independent predictors of END. Infarct volume showed significant predictive value for END (AUC = 0.768), non-hemorrhagic END (AUC = 0.682), and especially hemorrhagic END (AUC = 0.825), with an optimal threshold of 35.5 mL. A nomogram incorporating these independent factors was developed to facilitate individualized risk prediction. Conclusion: Infarct volume is an independent predictor of END after EVT, with particularly strong predictive value for hemorrhagic END. Incorporating infarct volume into postoperative risk assessment may improve early identification and management of high-risk patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.